Delivery Order SPE2DB20D3101-SPE2DB23FRTX8

Award Date 8/7/23
Potential Completion Date 8/8/23
Potential Value $417
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $417.27 to Amerisourcebergen Drug Corporation. The order is for 120 mg/ml Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 23, 2023. Emgality is a medication used to treat conditions such as migraine and cluster headache. The Defense Logistics Agency leverages contracts such as this to efficiently procure pharmaceuticals and other medical supplies for...
The Defense Logistics Agency awarded a $2,065.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by August 15, 2023 in support of DLA programs. Emgality is a medication used to treat conditions such as migraine and cluster headaches. Amerisourcebergen will deliver the requested pharmaceutical products as the prime contractor, with no...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $834 to Amerisourcebergen Drug Corporation. The order is for 120 mg/ml Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day in August 2023. Emgality is used to treat conditions such as migraine and cluster headache. This order was issued under an existing DLA contract vehicle but details of the vehicle were not provided....
The Defense Logistics Agency awarded a $1,466.49 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The order is to supply the pharmaceutical product to a Defense Logistics Agency location in Conshohocken, Pennsylvania by September 25, 2023. Amerisourcebergen will perform as the prime contractor, with the Defense Logistics Agency as the funding agency. The delivery order was issued under an existing DLA pharmaceutical supply vehicle and does not...
The Defense Logistics Agency awarded a $2,289.05 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The prime contractor will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania by August 22, 2023 under the terms of the order. Emgality is a monoclonal antibody used to treat migraine headaches. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical...
The Defense Logistics Agency awarded a $417 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As the prime contractor, Amerisourcebergen will deliver the pen injectors to its place of performance in Conshohocken, Pennsylvania by September 22, 2023 under the terms of this order. Emgality is used to treat conditions such as migraine and cluster headaches. The Defense Logistics Agency leverages contracts such as this to efficiently procure...
The Defense Logistics Agency awarded a $2,555.11 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 MG/ML Emgality pens. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by June 27, 2023 in support of the Defense Logistics Agency's medical supply needs. Emgality is a medication used to treat conditions such as migraine and cluster headaches. No set aside designation or subcontractors were identified. The...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $139,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation. The delivery order is for 120 mg/ml Emgality pens and will be performed in Conshohocken, Pennsylvania between July 26-27, 2023. Emgality is likely being procured to treat conditions such as migraine and cluster headaches for DOD personnel as part of the Agency's medical supply chain responsibilities. No set...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,669 to Amerisourcebergen Drug Corporation for 120mg/ml Emgality pens. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by June 29, 2023 under the terms of the order. Emgality is likely being procured to support DLA's mission to provide medical supplies and equipment to the U.S. military worldwide. No set aside designation...
The Defense Logistics Agency Troop Support Medical awarded a $417,270 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120mg/ml Emgality pens. As part of the Prime Vendor Pharmaceutical program supporting Department of Defense health care facilities, this order will supply Emgality, a monoclonal antibody for preventive treatment of migraine, from Amerisourcebergen's facility in Conshohocken, Pennsylvania for delivery between August 16-17, 2023. No subcontractors or set...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRTX8
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $417.27 to Amerisourcebergen Drug Corporation. The order is for 120 MG/ML Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 8, 2023. Emgality is a medication used to prevent migraine headaches. This delivery order was issued under the DLA's Pharmaceutical Prime Vendor contract, which establishes Amerisourcebergen as a primary supplier of prescription drugs and other pharmaceuticals to support the medical readiness of the U.S. Armed Forces. No subcontractors or set aside designations were indicated.

Generated 12/20/23, 3:01 AM